Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic

Clinical Infectious Diseases

Volumn 59, Issue 6, 2014, Pages 834-841

  Muzny, Christina A ^a   Blackburn, Reaford J ^b   Sinsky, Richard J ^c   Austin, Erika L ^a   Schwebke, Jane R ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c Jefferson County Department of Health   (United States)

Author keywords

Infectiousness; Nucleic acid amplification test; Sexually transmitted infection; Trichomonas vaginalis; Wet mount

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; DIAGNOSTIC TEST; FEMALE; GONORRHEA; HOSPITAL; HUMAN; INFECTION RISK; LEUKORRHEA; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; POLYMORPHONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; URETHRA; URINE; UTERINE CERVIX; VAGINA PH; GENETICS; MIDDLE AGED; PARASITOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; YOUNG ADULT;

ANTIPROTOZOAL AGENT; METRONIDAZOLE;

ADULT; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; TEXAS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; YOUNG ADULT;

EID: 84907418361     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu446     Document Type: Article

References (40)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections, 2001. Available at: http://www.who.int/hiv/pub/sti/who-hiv-aids-2001.02.pdf. Accessed 14 January 2014.
2. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26(suppl 4):S2-7.
3. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007; 45:1319-26.
4. Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012; 50:2601-8.
5. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-32.
6. Sutcliffe S, Newman SB, Hardick A, et al. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex Transm Dis 2010; 37:585-90.
7. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381-7.
8. Joyner JL, Douglas JM Jr, Ragsdale S. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis 2000; 27:236-40.
9. Borchardt KA, al-Haraci S, Maida N. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med 1995; 71:405-6.
10. Kaydos-Daniels SC, Miller WC, Hoffman I, et al. The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection. J Infect Dis 2004; 189:1926-31.
11. Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844-9.
12. Gaydos CA, Barnes MR, Quinn N, et al. Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment. Sex Transm Infect 2013; 89:504-8.
13. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
14. Cotch MF, Pastorek JG II, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-60.
15. Workowski KA, Berman S; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
16. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988; 259:1223-7.
17. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007; 45:194-8.
18. Hobbs MM, Sena AC, Swygard H, et al. Trichomonas vaginalis and trichomoniasis. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill, 2008:771-93.
19. Krieger JN, Verdon M, Siegel N, et al. Natural history of urogenital trichomoniasis in men. J Urol 1993; 149:1455-8.
20. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009; 200: 188. e1-7.
21. Schwebke JR, Hobbs MM, Taylor SN, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 2011; 49:4106-11.
22. Van Der Pol B, Williams JA, Taylor SN, et al. Trichomonas vaginalis DNA detection using self-obtained vaginal swabs with the BD ProbeTec Qx Assay on the BD Viper System. J Clin Microbiol 2014; 52:885-9.
23. Bachmann LH, Hobbs MM, Sena AC, et al. Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis 2011; 53(suppl 3): S160-72.
24. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
25. Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 2009; 36:738-44.
26. Divekar AA, Gogate AS, Shivkar LK, et al. Disease prevalence in women attending the STD clinic in Mumbai (formerly Bombay), India. Int J STD AIDS 2000; 11:45-8.
27. Lo M, Reid M, Brokenshire M. Epidemiological features of women with trichomoniasis in Auckland sexual health clinics: 1998-99. N Z Med J 2002; 115:U119.
28. Swygard H, Sena AC, Hobbs MM, et al. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect 2004; 80:91-5.
29. Garland SM, Tabrizi SN, Chen S, et al. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia. Infect Dis Obstet Gynecol 2001; 9:143-6.
30. Meites E, Llata E, Braxton J, et al. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence. Sex Transm Dis 2013; 40:865-9.
31. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens - a randomized clinical trial. Clin Infect Dis 2011; 52:163-70.
32. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147:89-96.
33. Lazenby GB, Soper DE, Nolte FS. Correlation of leukorrhea and Trichomonas vaginalis infection. J Clin Microbiol 2013; 51:2323-7.
34. Martin DH, Zozaya M, Lillis RA, et al. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis 2013; 207:1922-31.
35. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
36. Hillier SL, Krohn MA, Nugent RP, et al. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1992; 166:938-44.
37. Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010; 202:1907-15.
38. McGrory T, Meysick K, Lemchuk-Favel LT, et al. The interaction of Lactobacillus acidophilus and Trichomonas vaginalis in vitro. J Parasitol 1994; 80:50-4.
39. Rein MF, Muller M. Trichomonas vaginalis. In: Holmes KK, Mardh PA, Sparling PF, Weisner PJ, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1984: 525-35.
40. Lossick JG. Epidemiology of urogenital trichomoniasis. In: Honigberg BM, ed. Trichomonads parasitic in humans. New York: Springer-Verlag, 1989:311-23.